Financial Analysis of Cardiovascular Wellness Program Provided to Self-Insured Company from Pharmaceutical Care Provider’s Perspective
Authors:
- Justin B. WilsonJWJustin B. Wilson
- Matt C. OsterhausMOMatt C. Osterhaus
- Karen B. FarrisKFKaren B. Farris
- William R. DoucetteWDWilliam R. Doucette
- Jay D. CurrieJCJay D. Currie
- Tammy BullockTBTammy Bullock
- Patty KumberaPKPatty Kumbera
- 1 September 2005
- journal article
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 45 (5) , 588-592
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Patient Self-Management Program for Diabetes: First-Year Clinical, Humanistic, and Economic OutcomesJournal of the American Pharmacists Association, 2005
- Cost Implications of the Use of Ramipril in High-Risk Patients Based on the Heart Outcomes Prevention Evaluation (HOPE) StudyCirculation, 2003
- The Importance of Indirect Costs in Primary Cardiovascular Disease PreventionArchives of internal medicine (1960), 2003